Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells
- 15 June 2012
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 11 (12) , 2314-2326
Abstract
Hyperglycemia during hyper-CVAD chemotherapy is associated with poor outcomes of acute lymphoblastic leukemia (ALL) (Cancer 2004; 100:1179–85). The optimal clinical strategy to manage hyperglycemia...Keywords
This publication has 63 references indexed in Scilit:
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic CancerClinical Cancer Research, 2012
- The impact of type 2 diabetes and antidiabetic drugs on cancer cell growthJournal of Cellular and Molecular Medicine, 2011
- Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patientsAnnals of Oncology, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Combined randomised controlled trial experience of malignancies in studies using insulin glargineDiabetologia, 2009
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology GroupDiabetologia, 2009
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort studyDiabetologia, 2009
- Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF‐IR Intracellular SignalingPPAR Research, 2008
- On the Origin of Cancer CellsScience, 1956